Evaluation of the efficacy and safety of plasma exeresis in periorbital rejuvenation using the Reviscometer®

J Cosmet Dermatol. 2022 Jun;21(6):2550-2558. doi: 10.1111/jocd.14418. Epub 2021 Sep 14.

Abstract

Background: Periorbital rejuvenation is performed through various methods. Recently, plasma exeresis has been suggested for the treatment of dermatochalasis and periorbital wrinkles.

Aims: To evaluate the clinical efficacy and safety of plasma exeresis in periorbital rejuvenation and palpebral laxity and assess its effectiveness using the Reviscometer® .

Patients/methods: Fifty-six women with mild-to-severe dermatochalasis and periorbital wrinkles volunteered to participate in this clinical trial. They received plasma exeresis thrice at one-month intervals. The efficacy of the intervention was evaluated according to the Cutaneous Resonance Running Time (CRRT) value changes, photographic changes, patients' satisfaction, and clinical side effects.

Results: This study showed significant clinical improvements in dermatochalasis and palpebral laxity after treatment compared with the baseline (p < 0.001). Most of the participants had relative satisfaction, and no significant or permanent side effects were observed.

Conclusion: The findings of this study suggest that plasma exeresis is a safe and effective nonsurgical method for periorbital rejuvenation. Furthermore, the procedure has no serious adverse effects if performed correctly and for the right patient.

Keywords: dermatochalasis; palpebral laxity; periorbital rejuvenation; plasma exeresis.

Publication types

  • Clinical Trial

MeSH terms

  • Face
  • Female
  • Humans
  • Patient Satisfaction
  • Rejuvenation*
  • Skin Aging*
  • Treatment Outcome